Liquidia Corp
Biopharmaceutical company developing therapies for rare cardiopulmonary diseases.
LQDA | US
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 419 DAVIS DRIVE, SUITE 100, 27560 MORRISVILLE
- Website:
- https://www.liquidia.com/
- Sector:
- Manufacturing
Description
Liquidia Corp is a biopharmaceutical company dedicated to the development and commercialization of therapies for rare cardiopulmonary diseases. The company focuses on addressing unmet needs in conditions such as pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). A core component of its strategy is the proprietary PRINT® technology, a particle engineering platform used to create precisely uniform drug particles. This technology is designed to enhance the efficacy, tolerability, and convenience of medicines, particularly through innovative delivery methods like inhaled therapies. Liquidia's pipeline is focused on advancing treatments to improve outcomes for patients with these serious diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Liquidia Corp filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Liquidia Corp
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Liquidia Corp via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
